DE69712172T2 - Propiophenonderivate und Verfahren zu ihrer Herstellung - Google Patents
Propiophenonderivate und Verfahren zu ihrer HerstellungInfo
- Publication number
- DE69712172T2 DE69712172T2 DE69712172T DE69712172T DE69712172T2 DE 69712172 T2 DE69712172 T2 DE 69712172T2 DE 69712172 T DE69712172 T DE 69712172T DE 69712172 T DE69712172 T DE 69712172T DE 69712172 T2 DE69712172 T2 DE 69712172T2
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- propiophenone derivatives
- propiophenone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP34740696 | 1996-12-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69712172D1 DE69712172D1 (de) | 2002-05-29 |
DE69712172T2 true DE69712172T2 (de) | 2002-10-31 |
Family
ID=18390010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69712172T Expired - Lifetime DE69712172T2 (de) | 1996-12-26 | 1997-12-17 | Propiophenonderivate und Verfahren zu ihrer Herstellung |
Country Status (23)
Country | Link |
---|---|
US (1) | US6048842A (de) |
EP (1) | EP0850948B1 (de) |
KR (1) | KR100407029B1 (de) |
CN (1) | CN1094942C (de) |
AR (1) | AR010385A1 (de) |
AT (1) | ATE216704T1 (de) |
AU (1) | AU719726B2 (de) |
BG (1) | BG63546B1 (de) |
BR (1) | BR9706471B1 (de) |
CA (1) | CA2225439C (de) |
DE (1) | DE69712172T2 (de) |
DK (1) | DK0850948T3 (de) |
ES (1) | ES2176600T3 (de) |
HK (1) | HK1014960A1 (de) |
HU (1) | HU228514B1 (de) |
ID (1) | ID19290A (de) |
IL (1) | IL122666A (de) |
MY (1) | MY119350A (de) |
NO (1) | NO311804B1 (de) |
PT (1) | PT850948E (de) |
RU (1) | RU2156247C2 (de) |
TW (1) | TW406086B (de) |
ZA (1) | ZA9711560B (de) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1020944C (zh) * | 1990-01-30 | 1993-05-26 | 阿图尔-费希尔股份公司费希尔厂 | 紧固件 |
PH12000002657B1 (en) | 1999-10-12 | 2006-02-21 | Bristol Myers Squibb Co | C-aryl glucoside SGLT2 inhibitors |
US6515117B2 (en) | 1999-10-12 | 2003-02-04 | Bristol-Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
US6555519B2 (en) | 2000-03-30 | 2003-04-29 | Bristol-Myers Squibb Company | O-glucosylated benzamide SGLT2 inhibitors and method |
US6683056B2 (en) | 2000-03-30 | 2004-01-27 | Bristol-Myers Squibb Company | O-aryl glucoside SGLT2 inhibitors and method |
EP1338603B1 (de) | 2000-11-02 | 2010-01-20 | Ajinomoto Co., Inc. | Neue pyrazolderivate und diese enthaltende mittel gegen diabetes |
US6936590B2 (en) | 2001-03-13 | 2005-08-30 | Bristol Myers Squibb Company | C-aryl glucoside SGLT2 inhibitors and method |
DE60233655D1 (de) * | 2001-04-04 | 2009-10-22 | Ortho Mcneil Janssen Pharm | R und retinoid x rezeptorenmodulatoren |
DE60231295D1 (de) * | 2001-04-04 | 2009-04-09 | Ortho Mcneil Janssen Pharm | R und ppar modulatoren |
US7956041B2 (en) | 2002-04-26 | 2011-06-07 | Ajinomoto Co., Inc. | Prophylactic and therapeutic agent of diabetes mellitus |
AU2003231517A1 (en) * | 2002-04-26 | 2003-11-10 | Ajinomoto Co., Inc. | Preventive/remedy for diabetes |
EP1528066A4 (de) | 2002-08-09 | 2007-05-02 | Taisho Pharmaceutical Co Ltd | ARYL-t-THIO-B-GLUCOPYRANOSID DERIVATE UND DIABETESMITTEL, DIE DIESE ENTHALTEN |
DE10258008B4 (de) * | 2002-12-12 | 2006-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
DE10258007B4 (de) * | 2002-12-12 | 2006-02-09 | Sanofi-Aventis Deutschland Gmbh | Aromatische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel |
TW200504021A (en) | 2003-01-24 | 2005-02-01 | Bristol Myers Squibb Co | Substituted anilide ligands for the thyroid receptor |
US8785403B2 (en) | 2003-08-01 | 2014-07-22 | Mitsubishi Tanabe Pharma Corporation | Glucopyranoside compound |
EP1680414A4 (de) * | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | Substituierte indazol-o-glukoside |
WO2005012243A2 (en) * | 2003-08-01 | 2005-02-10 | Janssen Pharmaceutica N.V. | Substituted indole-o-glucosides |
MXPA06001274A (es) * | 2003-08-01 | 2006-04-11 | Tanabe Seiyaku Co | Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio. |
EP1679966A4 (de) * | 2003-08-01 | 2009-05-27 | Janssen Pharmaceutica Nv | Substituierte benzimidazol-, benzotriazol- und benzimidazolon-o-glukoside |
EA009768B1 (ru) * | 2003-08-01 | 2008-04-28 | Янссен Фармацевтика Нв | Замещенные конденсированные гетероциклические с-гликозиды |
FR2862303B1 (fr) * | 2003-11-17 | 2006-01-06 | Agronomique Inst Nat Rech | Preparations colorantes hydrosolubles jaunes derivees des dihydrochalcones, leur procede des preparation, et leurs utilisations |
DE102004028241B4 (de) * | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
TW200606129A (en) * | 2004-07-26 | 2006-02-16 | Chugai Pharmaceutical Co Ltd | Novel cyclohexane derivative, its prodrug, its salt and diabetic therapeutic agent containing the same |
TW200637869A (en) * | 2005-01-28 | 2006-11-01 | Chugai Pharmaceutical Co Ltd | The spiroketal derivatives and the use as therapeutical agent for diabetes of the same |
KR20090016456A (ko) | 2006-05-19 | 2009-02-13 | 다이쇼 세이야꾸 가부시끼가이샤 | 당뇨병 치료용 c-페닐글리시톨 화합물 |
DE102006028862A1 (de) | 2006-06-23 | 2007-12-27 | Merck Patent Gmbh | 3-Amino-imidazo[1,2-a]pyridinderivate |
KR20090023570A (ko) | 2006-06-29 | 2009-03-05 | 다이쇼 세이야꾸 가부시끼가이샤 | C-페닐 1-티오글루시톨 화합물 |
US7993687B2 (en) * | 2006-07-12 | 2011-08-09 | Julianne Marie Kawa | Compositions and methods for management of diabetes |
UY30730A1 (es) * | 2006-12-04 | 2008-07-03 | Mitsubishi Tanabe Pharma Corp | Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno |
CN101611023A (zh) | 2006-12-14 | 2009-12-23 | 大正制药株式会社 | 1-苯基1-硫代-d-山梨醇衍生物 |
DE102007008420A1 (de) | 2007-02-21 | 2008-08-28 | Merck Patent Gmbh | Benzimidazolderivate |
DK2200606T3 (en) * | 2007-09-10 | 2017-12-04 | Janssen Pharmaceutica Nv | PROCEDURE FOR THE PREPARATION OF RELATIONSHIP USED AS INHIBITORS OF SGLT |
DE102007048716A1 (de) | 2007-10-11 | 2009-04-23 | Merck Patent Gmbh | Imidazo[1,2-a]pyrimidinderivate |
CL2008003653A1 (es) | 2008-01-17 | 2010-03-05 | Mitsubishi Tanabe Pharma Corp | Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica. |
DE102008017590A1 (de) | 2008-04-07 | 2009-10-08 | Merck Patent Gmbh | Glucopyranosidderivate |
CN102105153B (zh) | 2008-05-22 | 2014-03-05 | 百时美施贵宝公司 | Sglt2抑制剂的医药用途和含该抑制剂的组合物 |
EP2334687B9 (de) | 2008-08-28 | 2012-08-08 | Pfizer Inc. | Dioxabicyclo[3.2.1]octan-2,3,4-triolderivate |
US9056850B2 (en) * | 2008-10-17 | 2015-06-16 | Janssen Pharmaceutica N.V. | Process for the preparation of compounds useful as inhibitors of SGLT |
US20110009347A1 (en) * | 2009-07-08 | 2011-01-13 | Yin Liang | Combination therapy for the treatment of diabetes |
PT2451797E (pt) | 2009-07-10 | 2013-06-25 | Janssen Pharmaceutica Nv | Processo de cristalização para o 1-(β-d-glucopiranosilo)-4-metilo-3-[5-(4-fluorofenilo)-2-tienilometilo]benzeno |
EP2298782A1 (de) * | 2009-08-26 | 2011-03-23 | Sanofi-Aventis | Verfahren zur Herstellung von Pyrazol-glykosid-Derivate |
ME02634B (de) * | 2009-10-14 | 2017-06-20 | Janssen Pharmaceutica Nv | Verfahren zur herstellung von sglt2-hemmenden verbindungen |
PT2496583E (pt) | 2009-11-02 | 2015-01-14 | Pfizer | Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
TWI599360B (zh) | 2010-05-11 | 2017-09-21 | 健生藥品公司 | 醫藥調配物 |
ME02469B (de) | 2011-04-13 | 2017-02-20 | Janssen Pharmaceutica Nv | Verfahren zur herstellung von sglt2-hemmenden verbindungen |
TWI542596B (zh) | 2011-05-09 | 2016-07-21 | 健生藥品公司 | (2s,3r,4r,5s,6r)-2-(3-((5-(4-氟苯基)噻吩-2-基)甲基)-4-甲基苯基)-6-(羥甲基)四氫-2h-哌喃-3,4,5-三醇之l-脯胺酸及檸檬酸共晶體 |
EP2774619B1 (de) | 2013-03-04 | 2016-05-18 | BioActive Food GmbH | Zusammensetzung zur Behandlung von hyperglykämischen Erkrankungen |
US20160033480A1 (en) * | 2013-12-16 | 2016-02-04 | Amy Huimeei Lo | Immunovir and Components, Immunovir A, B, C, D Utility and Useful Processes |
EP2944311A1 (de) | 2014-05-16 | 2015-11-18 | BioActive Food GmbH | Kombination von biologisch aktiven Substanzen zur Behandlung von hyperglykämischen Erkrankungen |
CN104478956A (zh) * | 2015-01-14 | 2015-04-01 | 佛山市赛维斯医药科技有限公司 | 苯基双o-葡萄糖苷衍生物、其制备方法和用途 |
CN104497069A (zh) * | 2015-01-15 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一类胺基苯基s-葡萄糖苷衍生物、其制备方法和用途 |
CN104497068A (zh) * | 2015-01-15 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一种含三氟甲氧基苯s-葡萄糖苷结构的化合物及其用途 |
CN104478961A (zh) * | 2015-01-15 | 2015-04-01 | 佛山市赛维斯医药科技有限公司 | 含丙烯腈和胺基苯o-葡萄糖苷结构衍生物、其制备方法和用途 |
CN104497071A (zh) * | 2015-01-15 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一种含丙烯腈基和腈基苯o-葡萄糖苷结构化合物及用途 |
US20170071970A1 (en) | 2015-09-15 | 2017-03-16 | Janssen Pharmaceutica Nv | Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders |
CN107827753A (zh) * | 2017-11-14 | 2018-03-23 | 湖北工业大学 | 一种对甲基二乙酰氧基碘苯的制备方法 |
CA3105626A1 (en) | 2018-07-19 | 2020-01-23 | Astrazeneca Ab | Methods of treating hfpef employing dapagliflozin and compositions comprising the same |
US20220023252A1 (en) | 2020-07-27 | 2022-01-27 | Astrazeneca Ab | Methods of treating chronic kidney disease with dapagliflozin |
AU2022251165A1 (en) | 2021-04-01 | 2023-11-09 | Astrazeneca Uk Limited | Systems and methods for managing prediabetes with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition |
WO2023144722A1 (en) | 2022-01-26 | 2023-08-03 | Astrazeneca Ab | Dapagliflozin for use in the treatment of prediabetes or reducing the risk of developing type 2 diabetes |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3984394A (en) * | 1971-05-14 | 1976-10-05 | Nutrilite Products, Inc. | Salts of dihydrochalcone derivatives and their use as sweeteners |
US4031260A (en) * | 1971-05-14 | 1977-06-21 | Nutrilite Products, Inc. | Salts of dihydrochalcone derivatives and their use as sweeteners |
US4684627A (en) * | 1981-09-08 | 1987-08-04 | Leveen Harry H | Treatment of cancer with phlorizin and its derivatives |
US5110801A (en) * | 1984-08-13 | 1992-05-05 | Leveen Harry H | Treatment of acne |
CA1289077C (en) * | 1984-08-13 | 1991-09-17 | Harry H. Leveen | Treatment of cancer with phlorizin and its derivatives |
US4760135A (en) * | 1984-09-06 | 1988-07-26 | University Of Kentucky Research Foundation | Phloretin and phlorizin derivative containing compounds |
US4665058A (en) * | 1985-03-16 | 1987-05-12 | The University Of Kentucky Research Foundation | Compositions and method of treatment for sickle cell anemia |
CA2102591C (en) * | 1992-11-12 | 2000-12-26 | Kenji Tsujihara | Hypoglycemic agent |
US5830873A (en) * | 1994-05-11 | 1998-11-03 | Tanabe Seiyaku Co., Ltd. | Propiophenone derivative and a process for preparing the same |
JP2847696B2 (ja) * | 1994-05-11 | 1999-01-20 | 田辺製薬株式会社 | プロピオフェノン誘導体及びその製法 |
JP3059088B2 (ja) * | 1995-11-07 | 2000-07-04 | 田辺製薬株式会社 | プロピオフェノン誘導体およびその製法 |
-
1997
- 1997-12-17 ES ES97122279T patent/ES2176600T3/es not_active Expired - Lifetime
- 1997-12-17 EP EP97122279A patent/EP0850948B1/de not_active Expired - Lifetime
- 1997-12-17 AT AT97122279T patent/ATE216704T1/de active
- 1997-12-17 AU AU48416/97A patent/AU719726B2/en not_active Ceased
- 1997-12-17 TW TW086119107A patent/TW406086B/zh not_active IP Right Cessation
- 1997-12-17 DK DK97122279T patent/DK0850948T3/da active
- 1997-12-17 DE DE69712172T patent/DE69712172T2/de not_active Expired - Lifetime
- 1997-12-17 PT PT97122279T patent/PT850948E/pt unknown
- 1997-12-18 IL IL12266697A patent/IL122666A/xx not_active IP Right Cessation
- 1997-12-18 US US08/993,523 patent/US6048842A/en not_active Expired - Lifetime
- 1997-12-18 MY MYPI97006145A patent/MY119350A/en unknown
- 1997-12-22 CA CA002225439A patent/CA2225439C/en not_active Expired - Fee Related
- 1997-12-23 HU HU9702534A patent/HU228514B1/hu not_active IP Right Cessation
- 1997-12-23 NO NO19976072A patent/NO311804B1/no not_active IP Right Cessation
- 1997-12-23 BG BG102148A patent/BG63546B1/bg unknown
- 1997-12-23 ID IDP973965A patent/ID19290A/id unknown
- 1997-12-24 CN CN97107281A patent/CN1094942C/zh not_active Expired - Fee Related
- 1997-12-25 RU RU97122334/04A patent/RU2156247C2/ru not_active IP Right Cessation
- 1997-12-26 BR BRPI9706471-8A patent/BR9706471B1/pt not_active IP Right Cessation
- 1997-12-26 ZA ZA9711560A patent/ZA9711560B/xx unknown
- 1997-12-26 KR KR1019970074439A patent/KR100407029B1/ko not_active IP Right Cessation
- 1997-12-26 AR ARP970106183A patent/AR010385A1/es active IP Right Grant
-
1998
- 1998-12-31 HK HK98119268A patent/HK1014960A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69712172T2 (de) | Propiophenonderivate und Verfahren zu ihrer Herstellung | |
DE69518031T2 (de) | Feste fettlösliche Zusammensetzung und Verfahren zu ihrer Herstellung | |
DE59606535D1 (de) | Furnacerusse und Verfahren zu ihrer Herstellung | |
DE69629525D1 (de) | Leichtvernetzte Poly-N-Alkylmethylsiloxane und Verfahren zu ihrer Herstellung | |
DE69609699D1 (de) | Klathrat-Verbindungen und Verfahren zu ihrer Herstellung | |
DE69522372D1 (de) | Polyasparaginsäurederivate und Verfahren zu ihrer Herstellung | |
DE69716420D1 (de) | Bitumenzusammensetzungen und verfahren zu ihrer herstellung | |
DE69510774T2 (de) | Katschukzusammensetzung und verfahren zu ihrer herstellung | |
DE69608490T2 (de) | Maltitol Zusammensetzung und Verfahren zu ihrer Herstellung | |
DE69801795T2 (de) | Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung | |
DE69523571D1 (de) | Pyridylimidazol-derivate und verfahren zu ihrer herstellung | |
DE69520118D1 (de) | Cyclopropanderivate und Verfahren zu ihrer Herstellung | |
DE69502772T2 (de) | Baccatinderivate und Verfahren zu ihrer Herstellung | |
DE69705565T2 (de) | Farbstoffzusammensetzungen und Verfahren zu ihrer Herstellung | |
DE69527445D1 (de) | Aminooligosaccharid-derivate und verfahren zu ihrer herstellung | |
DE69835180D1 (de) | Mikrostruktur und Verfahren zu ihrer Herstellung | |
DE69519713T2 (de) | Diaminoverbindungen und Verfahren zu ihrer Herstellung | |
DE69528860D1 (de) | 1-Amino-2-Cyclohexenderivate und Verfahren zu ihrer Herstellung | |
DE69841429D1 (de) | Feinstruktur und Verfahren zu ihrer Herstellung | |
DE69718308D1 (de) | 4-fluorsalicylsäurederivate und verfahren zu ihrer herstellung | |
ATE215553T1 (de) | Erythromycin-derivate, verfahren zu ihrer herstellung und ihrer verwendung | |
DE59403693D1 (de) | 4-Alkyl-3-chlor-benzolsulfinsäuren,4-Alkyl-3-chlor-benzolsulfonylcarbonsäuren, 4-Alkyl-3-chlor-alkylsulfonylbenzole und Verfahren zu ihrer Herstellung | |
DE69823866D1 (de) | Substanz ft-0554 und verfahren zu ihrer herstellung | |
DE69606662T2 (de) | Dianilinoglutacondialdehyd-Verbindungen und Verfahren zu ihrer Herstellung | |
DE59708528D1 (de) | Furfurylthioalkane, Verfahren zu ihrer Herstellung und ihre Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |